Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study.

BMC Med Imaging · 2021 · PMC8077911 · PMID 33902469

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

marginally significantp = 0.073so close (0.05 < p ≤ 0.1)

In the validation cohort, the difference in DFS between patients with low-T 1 WI_NGTDM_Strength and high-T 1 WI_NGTDM_Strength and the difference between patients with PDAC on the pancreatic head and that in other locations were approved, with marginally significant ( p = 0.073 and 0.050), respectively.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.